Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Majelco Medical is a private University of Utah spin-out developing HEMOPTiX, a proprietary disposable medical device for real-time measurement of surgical blood loss in operating room suction canisters. The device uses optical technology to determine hemoglobin concentration and fluid volume, enabling more accurate estimation of blood loss during moderate blood loss surgeries. The company positions its product as a tool to improve intraoperative fluid and transfusion decisions, reduce unnecessary transfusions, and lower complication-related costs. Majelco Medical appears to be a seed-stage, prototype-stage medtech company rather than a therapeutics developer, with commercialization efforts centered on anesthesia care, surgical workflow, and patient blood management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Majelco Medical.